Please Wait
Applying Filters...
menu
    • menu
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Wanbang Biopharmaceuticals

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1Aceglutamide

    02 1Apixaban

    03 1Calcium Dobesilate

    04 1Fasudil

    05 1Febuxostat

    06 1Glimepiride

    07 1Heparin Sodium

    08 1Insulin Lispro

    09 1Insulin, Regular, Pork

    10 1Perphenazine

    11 1Pitavastatin

    12 1Propylthiouracil

    13 1Tetracaine Hydrochloride

    14 1Ticagrelor

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
      • fda
      • EDQM
      • WHO-GMP
      Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
      Post an Enquiry Post an Enquiry
      Flag China
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Aceglutamide

      Product
      Web Link

      Stock Recap
      #PipelineProspector

      Market
      Place

      Wanbang Biopharmaceuticals is a leading anti-diabetic pharmaceutical company in China and a core member of Fosun Group (SH600196; HK02196). Wanbang Biopharma has been focusing at the development, manufacture and sale of pharmaceuticals to address the unmet medical needs in the area of diabetic disease since its establishment in 1981.As the pioneer ...
      Wanbang Biopharmaceuticals is a leading anti-diabetic pharmaceutical company in China and a core member of Fosun Group (SH600196; HK02196). Wanbang Biopharma has been focusing at the development, manufacture and sale of pharmaceuticals to address the unmet medical needs in the area of diabetic disease since its establishment in 1981.As the pioneer insulin producer in China, Wanbang has been developed into the largest anti-diabetic pharmaceutical provider of China with a comprehensive product portfolio that covers a wide range of anti-diabetic drugs, serving for more than eight million diabetic patients.
      blank

      01

      Aceglutamide

      China
      AMWC Asia-TDAC
      Not Confirmed
      arrow

      Aceglutamide

      China
      arrow
      AMWC Asia-TDAC
      Not Confirmed
      • fda
      • EDQM
      • WHO-GMP
      Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
      Post an Enquiry Post an Enquiry
      Flag China
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Wanbang Biopharmaceuticals

      Wanbang Biopharmaceuticals is a leading anti-diabetic pharmaceutical company in China and a core member of Fosun Group (SH600196; HK02196). Wanbang Biopharma has been focusing at the development, manufacture and sale of pharmaceuticals to address the unmet medical needs in the area of diabetic disease since its establishment in 1981.As the pioneer insulin producer in China, Wanbang has been developed into the largest anti-diabetic pharmaceutical provider of China with a comprehensive product portfolio that covers a wide range of anti-diabetic drugs, serving for more than eight million diabetic patients.

      About the Company : Wanbang Biopharmaceuticals is a leading anti-diabetic pharmaceutical company in China and a core member of Fosun Group (SH600196; HK02196). Wanbang Biopharma has been focusing at the development...

      blank

      Product
      Web Link

      Stock Recap
      #Pipeline Prospector

      Market
      Place

      Contact Supplier
        • fda
        • EDQM
        • WHO-GMP
        Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
        Post an Enquiry Post an Enquiry
        Flag China
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        Apixaban

        Product
        Web Link

        Stock Recap
        #PipelineProspector

        Market
        Place

        Wanbang Biopharmaceuticals is a leading anti-diabetic pharmaceutical company in China and a core member of Fosun Group (SH600196; HK02196). Wanbang Biopharma has been focusing at the development, manufacture and sale of pharmaceuticals to address the unmet medical needs in the area of diabetic disease since its establishment in 1981.As the pioneer ...
        Wanbang Biopharmaceuticals is a leading anti-diabetic pharmaceutical company in China and a core member of Fosun Group (SH600196; HK02196). Wanbang Biopharma has been focusing at the development, manufacture and sale of pharmaceuticals to address the unmet medical needs in the area of diabetic disease since its establishment in 1981.As the pioneer insulin producer in China, Wanbang has been developed into the largest anti-diabetic pharmaceutical provider of China with a comprehensive product portfolio that covers a wide range of anti-diabetic drugs, serving for more than eight million diabetic patients.
        blank

        02

        Apixaban

        China
        AMWC Asia-TDAC
        Not Confirmed
        arrow

        Apixaban

        China
        arrow
        AMWC Asia-TDAC
        Not Confirmed
        • fda
        • EDQM
        • WHO-GMP
        Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
        Post an Enquiry Post an Enquiry
        Flag China
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        Wanbang Biopharmaceuticals

        Wanbang Biopharmaceuticals is a leading anti-diabetic pharmaceutical company in China and a core member of Fosun Group (SH600196; HK02196). Wanbang Biopharma has been focusing at the development, manufacture and sale of pharmaceuticals to address the unmet medical needs in the area of diabetic disease since its establishment in 1981.As the pioneer insulin producer in China, Wanbang has been developed into the largest anti-diabetic pharmaceutical provider of China with a comprehensive product portfolio that covers a wide range of anti-diabetic drugs, serving for more than eight million diabetic patients.

        About the Company : Wanbang Biopharmaceuticals is a leading anti-diabetic pharmaceutical company in China and a core member of Fosun Group (SH600196; HK02196). Wanbang Biopharma has been focusing at the development...

        blank

        Product
        Web Link

        Stock Recap
        #Pipeline Prospector

        Market
        Place

        Contact Supplier
          • fda
          • EDQM
          • WHO-GMP
          Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
          Post an Enquiry Post an Enquiry
          Flag China
          Virtual Booth Virtual Booth
          Digital Content Digital Content

          Calcium Dobesilate

          Product
          Web Link

          Stock Recap
          #PipelineProspector

          Market
          Place

          Wanbang Biopharmaceuticals is a leading anti-diabetic pharmaceutical company in China and a core member of Fosun Group (SH600196; HK02196). Wanbang Biopharma has been focusing at the development, manufacture and sale of pharmaceuticals to address the unmet medical needs in the area of diabetic disease since its establishment in 1981.As the pioneer ...
          Wanbang Biopharmaceuticals is a leading anti-diabetic pharmaceutical company in China and a core member of Fosun Group (SH600196; HK02196). Wanbang Biopharma has been focusing at the development, manufacture and sale of pharmaceuticals to address the unmet medical needs in the area of diabetic disease since its establishment in 1981.As the pioneer insulin producer in China, Wanbang has been developed into the largest anti-diabetic pharmaceutical provider of China with a comprehensive product portfolio that covers a wide range of anti-diabetic drugs, serving for more than eight million diabetic patients.
          blank

          03

          Calcium Dobesilate

          China
          AMWC Asia-TDAC
          Not Confirmed
          arrow

          Calcium Dobesilate

          China
          arrow
          AMWC Asia-TDAC
          Not Confirmed
          • fda
          • EDQM
          • WHO-GMP
          Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
          Post an Enquiry Post an Enquiry
          Flag China
          Virtual Booth Virtual Booth
          Digital Content Digital Content

          Wanbang Biopharmaceuticals

          Wanbang Biopharmaceuticals is a leading anti-diabetic pharmaceutical company in China and a core member of Fosun Group (SH600196; HK02196). Wanbang Biopharma has been focusing at the development, manufacture and sale of pharmaceuticals to address the unmet medical needs in the area of diabetic disease since its establishment in 1981.As the pioneer insulin producer in China, Wanbang has been developed into the largest anti-diabetic pharmaceutical provider of China with a comprehensive product portfolio that covers a wide range of anti-diabetic drugs, serving for more than eight million diabetic patients.

          About the Company : Wanbang Biopharmaceuticals is a leading anti-diabetic pharmaceutical company in China and a core member of Fosun Group (SH600196; HK02196). Wanbang Biopharma has been focusing at the development...

          blank

          Product
          Web Link

          Stock Recap
          #Pipeline Prospector

          Market
          Place

          Contact Supplier
            • fda
            • EDQM
            • WHO-GMP
            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
            Post an Enquiry Post an Enquiry
            Flag China
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            Fasudil

            Product
            Web Link

            Stock Recap
            #PipelineProspector

            Market
            Place

            Wanbang Biopharmaceuticals is a leading anti-diabetic pharmaceutical company in China and a core member of Fosun Group (SH600196; HK02196). Wanbang Biopharma has been focusing at the development, manufacture and sale of pharmaceuticals to address the unmet medical needs in the area of diabetic disease since its establishment in 1981.As the pioneer ...
            Wanbang Biopharmaceuticals is a leading anti-diabetic pharmaceutical company in China and a core member of Fosun Group (SH600196; HK02196). Wanbang Biopharma has been focusing at the development, manufacture and sale of pharmaceuticals to address the unmet medical needs in the area of diabetic disease since its establishment in 1981.As the pioneer insulin producer in China, Wanbang has been developed into the largest anti-diabetic pharmaceutical provider of China with a comprehensive product portfolio that covers a wide range of anti-diabetic drugs, serving for more than eight million diabetic patients.
            blank

            04

            Fasudil

            China
            AMWC Asia-TDAC
            Not Confirmed
            arrow

            Fasudil

            China
            arrow
            AMWC Asia-TDAC
            Not Confirmed
            • fda
            • EDQM
            • WHO-GMP
            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
            Post an Enquiry Post an Enquiry
            Flag China
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            Wanbang Biopharmaceuticals

            Wanbang Biopharmaceuticals is a leading anti-diabetic pharmaceutical company in China and a core member of Fosun Group (SH600196; HK02196). Wanbang Biopharma has been focusing at the development, manufacture and sale of pharmaceuticals to address the unmet medical needs in the area of diabetic disease since its establishment in 1981.As the pioneer insulin producer in China, Wanbang has been developed into the largest anti-diabetic pharmaceutical provider of China with a comprehensive product portfolio that covers a wide range of anti-diabetic drugs, serving for more than eight million diabetic patients.

            About the Company : Wanbang Biopharmaceuticals is a leading anti-diabetic pharmaceutical company in China and a core member of Fosun Group (SH600196; HK02196). Wanbang Biopharma has been focusing at the development...

            blank

            Product
            Web Link

            Stock Recap
            #Pipeline Prospector

            Market
            Place

            Contact Supplier
              • fda
              • EDQM
              • WHO-GMP
              Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
              Post an Enquiry Post an Enquiry
              Flag China
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              Febuxostat

              Product
              Web Link

              Stock Recap
              #PipelineProspector

              Market
              Place

              Wanbang Biopharmaceuticals is a leading anti-diabetic pharmaceutical company in China and a core member of Fosun Group (SH600196; HK02196). Wanbang Biopharma has been focusing at the development, manufacture and sale of pharmaceuticals to address the unmet medical needs in the area of diabetic disease since its establishment in 1981.As the pioneer ...
              Wanbang Biopharmaceuticals is a leading anti-diabetic pharmaceutical company in China and a core member of Fosun Group (SH600196; HK02196). Wanbang Biopharma has been focusing at the development, manufacture and sale of pharmaceuticals to address the unmet medical needs in the area of diabetic disease since its establishment in 1981.As the pioneer insulin producer in China, Wanbang has been developed into the largest anti-diabetic pharmaceutical provider of China with a comprehensive product portfolio that covers a wide range of anti-diabetic drugs, serving for more than eight million diabetic patients.
              blank

              05

              Febuxostat

              China
              AMWC Asia-TDAC
              Not Confirmed
              arrow

              Febuxostat

              China
              arrow
              AMWC Asia-TDAC
              Not Confirmed
              • fda
              • EDQM
              • WHO-GMP
              Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
              Post an Enquiry Post an Enquiry
              Flag China
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              Wanbang Biopharmaceuticals

              Wanbang Biopharmaceuticals is a leading anti-diabetic pharmaceutical company in China and a core member of Fosun Group (SH600196; HK02196). Wanbang Biopharma has been focusing at the development, manufacture and sale of pharmaceuticals to address the unmet medical needs in the area of diabetic disease since its establishment in 1981.As the pioneer insulin producer in China, Wanbang has been developed into the largest anti-diabetic pharmaceutical provider of China with a comprehensive product portfolio that covers a wide range of anti-diabetic drugs, serving for more than eight million diabetic patients.

              About the Company : Wanbang Biopharmaceuticals is a leading anti-diabetic pharmaceutical company in China and a core member of Fosun Group (SH600196; HK02196). Wanbang Biopharma has been focusing at the development...

              blank

              Product
              Web Link

              Stock Recap
              #Pipeline Prospector

              Market
              Place

              Contact Supplier
                • fda
                • EDQM
                • WHO-GMP
                Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
                Post an Enquiry Post an Enquiry
                Flag China
                Virtual Booth Virtual Booth
                Digital Content Digital Content

                Glimepiride

                Product
                Web Link

                Stock Recap
                #PipelineProspector

                Market
                Place

                Wanbang Biopharmaceuticals is a leading anti-diabetic pharmaceutical company in China and a core member of Fosun Group (SH600196; HK02196). Wanbang Biopharma has been focusing at the development, manufacture and sale of pharmaceuticals to address the unmet medical needs in the area of diabetic disease since its establishment in 1981.As the pioneer ...
                Wanbang Biopharmaceuticals is a leading anti-diabetic pharmaceutical company in China and a core member of Fosun Group (SH600196; HK02196). Wanbang Biopharma has been focusing at the development, manufacture and sale of pharmaceuticals to address the unmet medical needs in the area of diabetic disease since its establishment in 1981.As the pioneer insulin producer in China, Wanbang has been developed into the largest anti-diabetic pharmaceutical provider of China with a comprehensive product portfolio that covers a wide range of anti-diabetic drugs, serving for more than eight million diabetic patients.
                blank

                06

                Glimepiride

                China
                AMWC Asia-TDAC
                Not Confirmed
                arrow

                Glimepiride

                China
                arrow
                AMWC Asia-TDAC
                Not Confirmed
                • fda
                • EDQM
                • WHO-GMP
                Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
                Post an Enquiry Post an Enquiry
                Flag China
                Virtual Booth Virtual Booth
                Digital Content Digital Content

                Wanbang Biopharmaceuticals

                Wanbang Biopharmaceuticals is a leading anti-diabetic pharmaceutical company in China and a core member of Fosun Group (SH600196; HK02196). Wanbang Biopharma has been focusing at the development, manufacture and sale of pharmaceuticals to address the unmet medical needs in the area of diabetic disease since its establishment in 1981.As the pioneer insulin producer in China, Wanbang has been developed into the largest anti-diabetic pharmaceutical provider of China with a comprehensive product portfolio that covers a wide range of anti-diabetic drugs, serving for more than eight million diabetic patients.

                About the Company : Wanbang Biopharmaceuticals is a leading anti-diabetic pharmaceutical company in China and a core member of Fosun Group (SH600196; HK02196). Wanbang Biopharma has been focusing at the development...

                blank

                Product
                Web Link

                Stock Recap
                #Pipeline Prospector

                Market
                Place

                Contact Supplier
                  • fda
                  • EDQM
                  • WHO-GMP
                  Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
                  Post an Enquiry Post an Enquiry
                  Flag China
                  Virtual Booth Virtual Booth
                  Digital Content Digital Content

                  Heparin Sodium

                  Product
                  Web Link

                  Stock Recap
                  #PipelineProspector

                  Market
                  Place

                  Wanbang Biopharmaceuticals is a leading anti-diabetic pharmaceutical company in China and a core member of Fosun Group (SH600196; HK02196). Wanbang Biopharma has been focusing at the development, manufacture and sale of pharmaceuticals to address the unmet medical needs in the area of diabetic disease since its establishment in 1981.As the pioneer ...
                  Wanbang Biopharmaceuticals is a leading anti-diabetic pharmaceutical company in China and a core member of Fosun Group (SH600196; HK02196). Wanbang Biopharma has been focusing at the development, manufacture and sale of pharmaceuticals to address the unmet medical needs in the area of diabetic disease since its establishment in 1981.As the pioneer insulin producer in China, Wanbang has been developed into the largest anti-diabetic pharmaceutical provider of China with a comprehensive product portfolio that covers a wide range of anti-diabetic drugs, serving for more than eight million diabetic patients.
                  blank

                  07

                  Heparin Sodium

                  China
                  AMWC Asia-TDAC
                  Not Confirmed
                  arrow

                  Heparin Sodium

                  China
                  arrow
                  AMWC Asia-TDAC
                  Not Confirmed
                  • fda
                  • EDQM
                  • WHO-GMP
                  Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
                  Post an Enquiry Post an Enquiry
                  Flag China
                  Virtual Booth Virtual Booth
                  Digital Content Digital Content

                  Wanbang Biopharmaceuticals

                  Wanbang Biopharmaceuticals is a leading anti-diabetic pharmaceutical company in China and a core member of Fosun Group (SH600196; HK02196). Wanbang Biopharma has been focusing at the development, manufacture and sale of pharmaceuticals to address the unmet medical needs in the area of diabetic disease since its establishment in 1981.As the pioneer insulin producer in China, Wanbang has been developed into the largest anti-diabetic pharmaceutical provider of China with a comprehensive product portfolio that covers a wide range of anti-diabetic drugs, serving for more than eight million diabetic patients.

                  About the Company : Wanbang Biopharmaceuticals is a leading anti-diabetic pharmaceutical company in China and a core member of Fosun Group (SH600196; HK02196). Wanbang Biopharma has been focusing at the development...

                  blank

                  Product
                  Web Link

                  Stock Recap
                  #Pipeline Prospector

                  Market
                  Place

                  Contact Supplier
                    • fda
                    • EDQM
                    • WHO-GMP
                    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
                    Post an Enquiry Post an Enquiry
                    Flag China
                    Virtual Booth Virtual Booth
                    Digital Content Digital Content

                    Insulin Lispro

                    Product
                    Web Link

                    Stock Recap
                    #PipelineProspector

                    Market
                    Place

                    Wanbang Biopharmaceuticals is a leading anti-diabetic pharmaceutical company in China and a core member of Fosun Group (SH600196; HK02196). Wanbang Biopharma has been focusing at the development, manufacture and sale of pharmaceuticals to address the unmet medical needs in the area of diabetic disease since its establishment in 1981.As the pioneer ...
                    Wanbang Biopharmaceuticals is a leading anti-diabetic pharmaceutical company in China and a core member of Fosun Group (SH600196; HK02196). Wanbang Biopharma has been focusing at the development, manufacture and sale of pharmaceuticals to address the unmet medical needs in the area of diabetic disease since its establishment in 1981.As the pioneer insulin producer in China, Wanbang has been developed into the largest anti-diabetic pharmaceutical provider of China with a comprehensive product portfolio that covers a wide range of anti-diabetic drugs, serving for more than eight million diabetic patients.
                    blank

                    08

                    Insulin Lispro

                    China
                    AMWC Asia-TDAC
                    Not Confirmed
                    arrow

                    Insulin Lispro

                    China
                    arrow
                    AMWC Asia-TDAC
                    Not Confirmed
                    • fda
                    • EDQM
                    • WHO-GMP
                    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
                    Post an Enquiry Post an Enquiry
                    Flag China
                    Virtual Booth Virtual Booth
                    Digital Content Digital Content

                    Wanbang Biopharmaceuticals

                    Wanbang Biopharmaceuticals is a leading anti-diabetic pharmaceutical company in China and a core member of Fosun Group (SH600196; HK02196). Wanbang Biopharma has been focusing at the development, manufacture and sale of pharmaceuticals to address the unmet medical needs in the area of diabetic disease since its establishment in 1981.As the pioneer insulin producer in China, Wanbang has been developed into the largest anti-diabetic pharmaceutical provider of China with a comprehensive product portfolio that covers a wide range of anti-diabetic drugs, serving for more than eight million diabetic patients.

                    About the Company : Wanbang Biopharmaceuticals is a leading anti-diabetic pharmaceutical company in China and a core member of Fosun Group (SH600196; HK02196). Wanbang Biopharma has been focusing at the development...

                    blank

                    Product
                    Web Link

                    Stock Recap
                    #Pipeline Prospector

                    Market
                    Place

                    Contact Supplier
                      • fda
                      • EDQM
                      • WHO-GMP
                      Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
                      Post an Enquiry Post an Enquiry
                      Flag China
                      Virtual Booth Virtual Booth
                      Digital Content Digital Content

                      Insulin, Regular, Pork

                      Product
                      Web Link

                      Stock Recap
                      #PipelineProspector

                      Market
                      Place

                      Wanbang Biopharmaceuticals is a leading anti-diabetic pharmaceutical company in China and a core member of Fosun Group (SH600196; HK02196). Wanbang Biopharma has been focusing at the development, manufacture and sale of pharmaceuticals to address the unmet medical needs in the area of diabetic disease since its establishment in 1981.As the pioneer ...
                      Wanbang Biopharmaceuticals is a leading anti-diabetic pharmaceutical company in China and a core member of Fosun Group (SH600196; HK02196). Wanbang Biopharma has been focusing at the development, manufacture and sale of pharmaceuticals to address the unmet medical needs in the area of diabetic disease since its establishment in 1981.As the pioneer insulin producer in China, Wanbang has been developed into the largest anti-diabetic pharmaceutical provider of China with a comprehensive product portfolio that covers a wide range of anti-diabetic drugs, serving for more than eight million diabetic patients.
                      blank

                      09

                      Insulin, Regular, Pork

                      China
                      AMWC Asia-TDAC
                      Not Confirmed
                      arrow

                      Insulin, Regular, Pork

                      China
                      arrow
                      AMWC Asia-TDAC
                      Not Confirmed
                      • fda
                      • EDQM
                      • WHO-GMP
                      Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
                      Post an Enquiry Post an Enquiry
                      Flag China
                      Virtual Booth Virtual Booth
                      Digital Content Digital Content

                      Wanbang Biopharmaceuticals

                      Wanbang Biopharmaceuticals is a leading anti-diabetic pharmaceutical company in China and a core member of Fosun Group (SH600196; HK02196). Wanbang Biopharma has been focusing at the development, manufacture and sale of pharmaceuticals to address the unmet medical needs in the area of diabetic disease since its establishment in 1981.As the pioneer insulin producer in China, Wanbang has been developed into the largest anti-diabetic pharmaceutical provider of China with a comprehensive product portfolio that covers a wide range of anti-diabetic drugs, serving for more than eight million diabetic patients.

                      About the Company : Wanbang Biopharmaceuticals is a leading anti-diabetic pharmaceutical company in China and a core member of Fosun Group (SH600196; HK02196). Wanbang Biopharma has been focusing at the development...

                      blank

                      Product
                      Web Link

                      Stock Recap
                      #Pipeline Prospector

                      Market
                      Place

                      Contact Supplier
                        • fda
                        • EDQM
                        • WHO-GMP
                        Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
                        Post an Enquiry Post an Enquiry
                        Flag China
                        Virtual Booth Virtual Booth
                        Digital Content Digital Content

                        Perphenazine

                        Product
                        Web Link

                        Stock Recap
                        #PipelineProspector

                        Market
                        Place

                        Wanbang Biopharmaceuticals is a leading anti-diabetic pharmaceutical company in China and a core member of Fosun Group (SH600196; HK02196). Wanbang Biopharma has been focusing at the development, manufacture and sale of pharmaceuticals to address the unmet medical needs in the area of diabetic disease since its establishment in 1981.As the pioneer ...
                        Wanbang Biopharmaceuticals is a leading anti-diabetic pharmaceutical company in China and a core member of Fosun Group (SH600196; HK02196). Wanbang Biopharma has been focusing at the development, manufacture and sale of pharmaceuticals to address the unmet medical needs in the area of diabetic disease since its establishment in 1981.As the pioneer insulin producer in China, Wanbang has been developed into the largest anti-diabetic pharmaceutical provider of China with a comprehensive product portfolio that covers a wide range of anti-diabetic drugs, serving for more than eight million diabetic patients.
                        blank

                        10

                        Perphenazine

                        China
                        AMWC Asia-TDAC
                        Not Confirmed
                        arrow

                        Perphenazine

                        China
                        arrow
                        AMWC Asia-TDAC
                        Not Confirmed
                        • fda
                        • EDQM
                        • WHO-GMP
                        Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
                        Post an Enquiry Post an Enquiry
                        Flag China
                        Virtual Booth Virtual Booth
                        Digital Content Digital Content

                        Wanbang Biopharmaceuticals

                        Wanbang Biopharmaceuticals is a leading anti-diabetic pharmaceutical company in China and a core member of Fosun Group (SH600196; HK02196). Wanbang Biopharma has been focusing at the development, manufacture and sale of pharmaceuticals to address the unmet medical needs in the area of diabetic disease since its establishment in 1981.As the pioneer insulin producer in China, Wanbang has been developed into the largest anti-diabetic pharmaceutical provider of China with a comprehensive product portfolio that covers a wide range of anti-diabetic drugs, serving for more than eight million diabetic patients.

                        About the Company : Wanbang Biopharmaceuticals is a leading anti-diabetic pharmaceutical company in China and a core member of Fosun Group (SH600196; HK02196). Wanbang Biopharma has been focusing at the development...

                        blank

                        Product
                        Web Link

                        Stock Recap
                        #Pipeline Prospector

                        Market
                        Place

                        Contact Wanbang Biopharmaceuticals and get a quotation

                        Wanbang Biopharmaceuticals is a supplier offers 14 products (APIs, Excipients or Intermediates).

                        Find Febuxostat bulk with DMF offered by Wanbang Biopharmaceuticals

                        Find Pitavastatin bulk with DMF offered by Wanbang Biopharmaceuticals

                        Find Aceglutamide bulk offered by Wanbang Biopharmaceuticals

                        Find Apixaban bulk offered by Wanbang Biopharmaceuticals

                        Find Calcium Dobesilate bulk offered by Wanbang Biopharmaceuticals

                        Find Fasudil bulk offered by Wanbang Biopharmaceuticals

                        Find Glimepiride bulk offered by Wanbang Biopharmaceuticals

                        Find Heparin Sodium bulk offered by Wanbang Biopharmaceuticals

                        Find Insulin Lispro bulk offered by Wanbang Biopharmaceuticals

                        Find Insulin, Regular, Pork bulk offered by Wanbang Biopharmaceuticals

                        Find Perphenazine bulk offered by Wanbang Biopharmaceuticals

                        Find Propylthiouracil bulk offered by Wanbang Biopharmaceuticals

                        Find Tetracaine Hydrochloride bulk offered by Wanbang Biopharmaceuticals

                        Find Ticagrelor bulk offered by Wanbang Biopharmaceuticals

                        • Privacy policy
                        • Terms and conditions
                        • Disclaimers
                        • LinkedIn
                        • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.